Description
AUROSIL is fractionated, purified, sterile and apyrogenic
silicone oil designed for prolonged tamponade after surgical treatment for
severe retinal detachment.
-
Greater stability
-
Reduced emulsification due to a high degree of
purification and low level of reactive -OH end groups
-
Less tissue impregnation
-
Subject to all physical and chemical analysis
(H-NMR spectral test, gel permeation chromatography study and gas
chromatography) to ensure purity level
-
Low level of catalyst impurities minimize the risks
of interactions with the ocular environment
-
Quality product with a proven track record
Adverse Reactions
The most common adverse reactions include cataract, anterior
chamber oil migration, keratopathy and glaucoma. Other adverse reactions include
optic nerve atrophy, rubeosis iritis, temporary IOP increase, macular pucker,
vitreous hemorrhage, phthisis, traction detachment, angle block, subretinal
strands, retinal rupture, endophthalmitis, subretinal silicone oil, choroidal
detachment, aniridia and cystoid macular edema. Opacification of silicone IOL
has been reported (in-vitro).
